Abstract
Stem cell therapy has been heralded as a novel therapeutic option for cardiovascular disease. In vivo molecular imaging has emerged as an indispensible tool in investigating stem cell biology post-transplantation into the myocardium and in evaluating the therapeutic efficacy. This review highlights the features of each molecular imaging modality and discusses how these modalities have been applied to evaluate stem cell therapy.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Wollert KC, Meyer GP, Lotz J, et al.: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004, 364:141–148.
Stamm C, Kleine HD, Westphal B, et al.: CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac Cardiovasc Surg 2004, 52:152–158.
Assmus B, Schachinger V, Teupe C, et al.: Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002, 106:3009–3017.
Perin EC, Dohmann HF, Borojevic R, et al.: Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003, 107:2294–2302.
Orlic D, Kajstura J, Chimenti S, et al.: Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701–705.
Nygren JM, Jovinge S, Breitbach M, et al.: Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004, 10:494–501.
Murry CE, Soonpaa MH, Reinecke H, et al.: Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664–668.
Laflamme MA, Chen KY, Naumova AV, et al.: Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007, 25:1015–1024.
Liang HD, Blomley MJ: The role of ultrasound in molecular imaging. Br J Radiol 2003, 76:S140–S150.
Morawski AM, Lanza GA, Wickline SA: Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr Opin Biotechnol 2005, 16:89–92.
Villanueva FS, Jankowski RJ, Klibanov S, et al.: Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 1998, 98:1–5.
Demos SM, Dagar S, Klegerman M, et al.: In vitro targeting of acoustically reflective immunoliposomes to fibrin under various flow conditions. J Drug Target 1998, 5:507–518.
Bara C, Ghodsizad A, Niehaus M, et al.: In vivo echocardiographic imaging of transplanted human adult stem cells in the myocardium labeled with clinically applicable CliniMACS nanoparticles. J Am Soc Echocardiogr 2006, 19:563–568.
Aicher A, Brenner W, Zuhayra M, et al.: Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003, 107:2134–2139.
Hofmann M, Wollert KC, Meyer GP, et al.: Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005, 111:2198–2202.
Cao F, Lin S, Xie X, et al.: In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 2006, 113:1005–1014.
Cao YA, Wagers AJ, Beilhack A, et al.: Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A 2004, 101:221–226.
• Hendry SL 2nd, van der Bogt KE, Sheikh AY, et al.: Multimodal evaluation of in vivo magnetic resonance imaging of myocardial restoration by mouse embryonic stem cells. J Thorac Cardiovasc Surg 2008, 136:1028–1037; e1021. This study shows significance of transplanted cell viability to get therapeutic benefit.
Hung TC, Suzuki Y, Urashima T, et al.: Multimodality evaluation of the viability of stem cells delivered into different zones of myocardial infarction. Circ Cardiovasc Imaging 2008, 1:6–13.
Massoud TF, Singh A, Gambhir SS: Noninvasive molecular neuroimaging using reporter genes: part II, experimental, current, and future applications. AJNR Am J Neuroradiol 2008, 29:409–418.
Bulte JW, Douglas T, Witwer B, et al.: Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 2001, 19:1141–1147.
Aikawa E, Nahrendorf M, Sosnovik D, et al.: Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 2007, 115:377–386.
Schellenberger EA, Hogemann D, Josephson L, et al.: Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Acad Radiol 2002, 9(Suppl 2):S310–S311.
• Suzuki Y, Zhang S, Kundu P, et al.: In vitro comparison of the biological effects of three transfection methods for magnetically labeling mouse embryonic stem cells with ferumoxides. Magn Reson Med 2007, 57:1173–1179. This study shows SPIO labeling of stem cells does not affect the viability of cells.
Kostura L, Kraitchman DL, Mackay AM, et al.: Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 2004, 17:513–517.
Arai T, Kofidis T, Bulte JW, et al.: Dual in vivo magnetic resonance evaluation of magnetically labeled mouse embryonic stem cells and cardiac function at 1.5 t. Magn Reson Med 2006, 55:203–209.
• Chen IY, Greve JM, Gheysens O, et al.: Comparison of optical bioluminescence reporter gene and superparamagnetic iron oxide MR contrast agent as cell markers for noninvasive imaging of cardiac cell transplantation. Mol Imaging Biol 2009, 11:178–187. This study demonstrates SPIO direct labeling does not tell viability of transplanted cells.
Kraitchman DL, Heldman AW, Atalar E, et al.: In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003, 107:2290–2293.
Lin YJ, Koretsky AP: Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn Reson Med 1997, 38:378–388.
• Yamada M, Gurney PT, Chung J, et al.: Manganese-guided cellular MRI of human embryonic stem cell and human bone marrow stromal cell viability. Magn Reson Med 2009, 62:1047–1054. This study shows manganese labeling of stem cells does not affect biologic property of human embryonic and mesenchymal stem cells.
Bruvold M, Nordhoy W, Anthonsen HW, et al.: Manganese-calcium interactions with contrast media for cardiac magnetic resonance imaging: a study of manganese chloride supplemented with calcium gluconate in isolated Guinea pig hearts. Invest Radiol 2005, 40:117–125.
Bulte JW, Zhang S, van Gelderen P, et al.: Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A 1999, 96:15256–15261.
So PW, Hotee S, Herlihy AH, et al.: Generic method for imaging transgene expression. Magn Reson Med 2005, 54:218–221.
Weissleder R, Tung CH, Mahmood U, et al.: In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 1999, 17:375–378.
• Chung J, Kee K, Rajesh D, et al.: In vivo molecular MRI of embryonic stem cell survival kinetics following transplantation into murine injured myocardium. Circulation 2009, 120:A32. This is the first study to show in vivo viability of embryonic stem cells using an MRI reporter gene.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chung, J., Yang, P.C. Molecular Imaging of Stem Cell Transplantation in Myocardial Disease. curr cardiovasc imaging rep 3, 106–112 (2010). https://doi.org/10.1007/s12410-009-9001-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12410-009-9001-4